Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001209191-23-048779

Options or other derivatives

  • Director acquired 55,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bishop Hans Edgar · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-08 Grant or award : show line 1 in the form Option (right to buy) +55,000 $3.19 2033-09-07 55,000 55,000 D
Loading xslF345X05/doc4.xml…